메뉴 건너뛰기




Volumn 62, Issue 1, 1997, Pages 1-12

Cardiac potassium currents and channels Part II: Implications for clinical practice and therapy

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; 1' (6 CYANO 1,2,3,4 TETRAHYDRO 2 NAPHTHYL) 3,4 DIHYDRO 6 METHANESULFONAMIDOSPIRO[2H 1 BENZOPYRAN 2,4' PIPERIDIN] 4 OL; ALMOKALANT; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; APRIKALIM; ASTEMIZOLE; BIMAKALIM; CISAPRIDE; CROMAKALIM; DIAZOXIDE; DIURETIC AGENT; DOFETILIDE; ERYTHROMYCIN; FLECAINIDE ACETATE; IBUTILIDE FUMARATE; KETOCONAZOLE; MINOXIDIL; NICORANDIL; PINACIDIL; PLACEBO; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM ION; SEMATILIDE; SOTALOL; TEDISAMIL; TERFENADINE; UNINDEXED DRUG;

EID: 0030728142     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00169-1     Document Type: Article
Times cited : (5)

References (79)
  • 1
    • 0021207214 scopus 로고
    • A classification of antiarrhythmic actions reassessed after a decade of new drugs
    • Vaughan Williams E.M. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol. 24:1984;129-147.
    • (1984) J Clin Pharmacol , vol.24 , pp. 129-147
    • Vaughan Williams, E.M.1
  • 2
    • 0025676658 scopus 로고
    • Channel specificity in antiarrhythmic drug action: Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias
    • Colatsky T.J., Follmer C.H., Starmer C.F. Channel specificity in antiarrhythmic drug action: mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation. 92:1990;2235-2242.
    • (1990) Circulation , vol.92 , pp. 2235-2242
    • Colatsky, T.J.1    Follmer, C.H.2    Starmer, C.F.3
  • 3
    • 0027485907 scopus 로고
    • Arrhythmia control by prolongating repolarization: The concept and its potential therapeutic impact
    • Singh B.N. Arrhythmia control by prolongating repolarization: the concept and its potential therapeutic impact. Eur Heart J. 14(suppl H.):1993;14-23.
    • (1993) Eur Heart J , vol.14 , Issue.SUPPL. H. , pp. 14-23
    • Singh, B.N.1
  • 4
    • 0026050195 scopus 로고
    • A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms
    • The Sicilian Gambit. Task Force of the Working Group on arrhythmias of the European Society of Cardiology
    • The Sicilian Gambit. Task Force of the Working Group on arrhythmias of the European Society of Cardiology. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991, 84: 1831-51.
    • (1991) Circulation , vol.84 , pp. 1831-1851
  • 5
    • 0027371046 scopus 로고
    • New class III antiarrhythmic drugs
    • Katristis D., Camm A.J. New class III antiarrhythmic drugs. Eur Heart J. 14(suppl H):1993;93-99.
    • (1993) Eur Heart J , vol.14 , Issue.SUPPL. H , pp. 93-99
    • Katristis, D.1    Camm, A.J.2
  • 7
    • 0029057635 scopus 로고
    • Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells
    • Mori K., Hara Y., Saito T., Masuda Y., Nakaya H. Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Circulation. 91:1995;2834-2843.
    • (1995) Circulation , vol.91 , pp. 2834-2843
    • Mori, K.1    Hara, Y.2    Saito, T.3    Masuda, Y.4    Nakaya, H.5
  • 8
    • 0024321898 scopus 로고
    • The Cardiac Arrhythmia Suppression Trial (CAST) Investigators preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
    • The Cardiac Arrhythmia Suppression Trial (CAST) Investigators preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989, 321: 406-412.
    • (1989) N Engl J Med , vol.321 , pp. 406-412
  • 9
    • 0023158384 scopus 로고
    • Amiodarone
    • Mason J.W. Amiodarone. N Engl J Med. 316:1987;455-465.
    • (1987) N Engl J Med , vol.316 , pp. 455-465
    • Mason, J.W.1
  • 11
    • 0030025539 scopus 로고    scopus 로고
    • Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias
    • Levine J.M., Massumi A., Scheinman M.S.et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol. 27:1996;67-75.
    • (1996) J Am Coll Cardiol , vol.27 , pp. 67-75
    • Levine, J.M.1    Massumi, A.2    Scheinman, M.S.3
  • 12
    • 0027201134 scopus 로고
    • The CASCADE investigators randomized antiarrhythmic drug therapy in survivors of cardiac arrest (CASCADE study)
    • The CASCADE investigators randomized antiarrhythmic drug therapy in survivors of cardiac arrest (CASCADE study). Am J Cardiol 1993, 72: 280-287.
    • (1993) Am J Cardiol , vol.72 , pp. 280-287
  • 13
    • 0025688313 scopus 로고
    • Effects of antiarrhythmic on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)
    • Burkart F., Pfisterer M., Kiowski W., Follath F., Burckhardt D. Effects of antiarrhythmic on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol. 16:1990;1711-1718.
    • (1990) J Am Coll Cardiol , vol.16 , pp. 1711-1718
    • Burkart, F.1    Pfisterer, M.2    Kiowski, W.3    Follath, F.4    Burckhardt, D.5
  • 14
    • 0026497728 scopus 로고
    • Effects of amiodarone on mortality after myocardial infarction: A double bind, placebo-controlled, pilot study
    • Ceremuzynski F., Kleczar E., Kreminska-Pakula M.et al. Effects of amiodarone on mortality after myocardial infarction: a double bind, placebo-controlled, pilot study. J Am Coll Cardiol. 20:1992;1051-1062.
    • (1992) J Am Coll Cardiol , vol.20 , pp. 1051-1062
    • Ceremuzynski, F.1    Kleczar, E.2    Kreminska-Pakula, M.3
  • 15
    • 0031029373 scopus 로고    scopus 로고
    • Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT
    • Cairns J.A., Connolly S.J., Roberts R., Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet. 349:1997;675-682.
    • (1997) Lancet , vol.349 , pp. 675-682
    • Cairns, J.A.1    Connolly, S.J.2    Roberts, R.3    Gent, M.4
  • 16
    • 0031038213 scopus 로고    scopus 로고
    • Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
    • Julian D.G., Camm A.J., Frangin G., Janse M.J., Munoz A., Schwartz P.J., Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet. 349:1997;667-674.
    • (1997) Lancet , vol.349 , pp. 667-674
    • Julian, D.G.1    Camm, A.J.2    Frangin, G.3    Janse, M.J.4    Munoz, A.5    Schwartz, P.J.6    Simon, P.7
  • 17
    • 0027998462 scopus 로고
    • Randomized trial of low-dose amiodarone in patients with severe congestive heart failure
    • Doval H.C., Nul D.R., Grancelli H.O., Perrone S.V., Bortman G.R., Curiel L. Randomized trial of low-dose amiodarone in patients with severe congestive heart failure. Lancet. 344:1994;493-498.
    • (1994) Lancet , vol.344 , pp. 493-498
    • Doval, H.C.1    Nul, D.R.2    Grancelli, H.O.3    Perrone, S.V.4    Bortman, G.R.5    Curiel, L.6
  • 18
    • 0029004921 scopus 로고
    • Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias
    • Singh S.N., Fletcher R.D., GrossFisher S.et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. N Engl J Med. 333:1995;77-82.
    • (1995) N Engl J Med , vol.333 , pp. 77-82
    • Singh, S.N.1    Fletcher, R.D.2    Grossfisher, S.3
  • 19
    • 0030958383 scopus 로고    scopus 로고
    • Heart rate is a marker of amiodarone mortality reduction in severe heart failure
    • Nul D.R., Doval H.C., Grancelli H.O.et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. J Am Coll Cardiol. 29:1997;1199-1205.
    • (1997) J Am Coll Cardiol , vol.29 , pp. 1199-1205
    • Nul, D.R.1    Doval, H.C.2    Grancelli, H.O.3
  • 20
    • 0028879487 scopus 로고
    • Efficacy and proarrhythmia of oral sotalol in pediatric patients
    • Pfammater J.P., Paul T., Lehmann C., Kallfelz H.C. Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol. 26:1995;1002-1007.
    • (1995) J Am Coll Cardiol , vol.26 , pp. 1002-1007
    • Pfammater, J.P.1    Paul, T.2    Lehmann, C.3    Kallfelz, H.C.4
  • 21
    • 0027296250 scopus 로고
    • Clinical safety profile of sotalol in the treatment of arrhythmias
    • MacNeil D.J., Davies R.O., Deitchman D. Clinical safety profile of sotalol in the treatment of arrhythmias. Am J Cardiol. 72:1993;44A-50A.
    • (1993) Am J Cardiol , vol.72
    • MacNeil, D.J.1    Davies, R.O.2    Deitchman, D.3
  • 23
    • 0027179547 scopus 로고
    • For the Electrophysiologic study versus electrocardiographic monitoring (ESVEM) investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias
    • Mason J.W. for the Electrophysiologic study versus electrocardiographic monitoring (ESVEM) investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med. 329:1993;445-451.
    • (1993) N Engl J Med , vol.329 , pp. 445-451
    • Mason, J.W.1
  • 24
    • 0029560485 scopus 로고
    • Long-term efficacy of D,L-sotalol in patients with sustained ventricular tachycardia refractory to class I. antiarrhythmic drugs
    • Kühlkamp V., Mermi J., Mewis C., Braun U., Seipel L. Long-term efficacy of D,L-sotalol in patients with sustained ventricular tachycardia refractory to class I. antiarrhythmic drugs. Eur Heart J. 16:1995;1625-1631.
    • (1995) Eur Heart J , vol.16 , pp. 1625-1631
    • Kühlkamp, V.1    Mermi, J.2    Mewis, C.3    Braun, U.4    Seipel, L.5
  • 25
    • 0029619196 scopus 로고
    • Effects of the new class III dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris
    • Sedgwick M.L., Dalrymple I., Rae A.P., Cobbe S.M. Effects of the new class III dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris. Eur Heart J. 16:1995;1641-1646.
    • (1995) Eur Heart J , vol.16 , pp. 1641-1646
    • Sedgwick, M.L.1    Dalrymple, I.2    Rae, A.P.3    Cobbe, S.M.4
  • 27
    • 0029002142 scopus 로고
    • Survival with oral D-sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design and methods (the SWORD trial)
    • Waldo A.l., Camm A.J., deRuyter H.et al. Survival with oral D-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design and methods (the SWORD trial). Am J Cardiol. 75:1995;1023-1027.
    • (1995) Am J Cardiol , vol.75 , pp. 1023-1027
    • Waldo, A.L.1    Camm, A.J.2    Deruyter, H.3
  • 29
    • 0031029739 scopus 로고    scopus 로고
    • Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter
    • Falk R.H., Pollak A., Singh S.N., Friedrich T. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. J Am Coll Cardiol. 29:1997;385-390.
    • (1997) J Am Coll Cardiol , vol.29 , pp. 385-390
    • Falk, R.H.1    Pollak, A.2    Singh, S.N.3    Friedrich, T.4
  • 30
    • 0000955544 scopus 로고
    • Comparison of intravenously-administered dofetilide-versus amiodarone in the acute termination of atrial fibrillation and flutter
    • Bianconi L., Dinelli M., Pappalardo A., Richiardi E., Castro A., Alboni P., Santini M., Dalrymple H.W., Radula D. Comparison of intravenously-administered dofetilide-versus amiodarone in the acute termination of atrial fibrillation and flutter. Circulation. 92(Suppl I):1995;I-774.
    • (1995) Circulation , vol.92 , Issue.SUPPL. I , pp. 774
    • Bianconi, L.1    Dinelli, M.2    Pappalardo, A.3    Richiardi, E.4    Castro, A.5    Alboni, P.6    Santini, M.7    Dalrymple, H.W.8    Radula, D.9
  • 31
    • 0028198795 scopus 로고
    • Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia
    • Yuan S., Wohlfart B., Rasmussen H.S., Olsson S., Blomstrom-Lundqvist C. Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia. Eur Heart J. 15:1994;514-522.
    • (1994) Eur Heart J , vol.15 , pp. 514-522
    • Yuan, S.1    Wohlfart, B.2    Rasmussen, H.S.3    Olsson, S.4    Blomstrom-Lundqvist, C.5
  • 32
    • 0028789950 scopus 로고
    • Electrophysiologic profile and efficacy of intravenous dofetilide, a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia
    • Bashir Y., Thomsen P.E., Kinema J.H.et al. Electrophysiologic profile and efficacy of intravenous dofetilide, a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Am J Cardiol. 76:1995;1040-1044.
    • (1995) Am J Cardiol , vol.76 , pp. 1040-1044
    • Bashir, Y.1    Thomsen, P.E.2    Kinema, J.H.3
  • 33
    • 0029819618 scopus 로고    scopus 로고
    • Diamond antiarrhythmic trials
    • Moller M. Diamond antiarrhythmic trials. Lancet. 348:1996;1597-1598.
    • (1996) Lancet , vol.348 , pp. 1597-1598
    • Moller, M.1
  • 34
    • 0027178719 scopus 로고
    • Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans
    • Sager P.T., Nedemanee K., Antimisiaris M.et al. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans. Circulation. 88:1993;1072-1082.
    • (1993) Circulation , vol.88 , pp. 1072-1082
    • Sager, P.T.1    Nedemanee, K.2    Antimisiaris, M.3
  • 35
    • 0028880376 scopus 로고
    • Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: A class III antiarrhythmic agent without cardiodepressant effects
    • Stambler B.S., Gottlieb S.S., Singh B.N., Ramanathan K.B., Ogilby J.D., Ellenbogen K.E. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects. J Am Coll Cardiol. 26:1995;1679-1684.
    • (1995) J Am Coll Cardiol , vol.26 , pp. 1679-1684
    • Stambler, B.S.1    Gottlieb, S.S.2    Singh, B.N.3    Ramanathan, K.B.4    Ogilby, J.D.5    Ellenbogen, K.E.6
  • 36
    • 9444256916 scopus 로고    scopus 로고
    • Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter
    • Ellenbogen K.A., Stambler B.S., Wood M.A.et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter. J Am Coll Cardiol. 28:1996;130-136.
    • (1996) J Am Coll Cardiol , vol.28 , pp. 130-136
    • Ellenbogen, K.A.1    Stambler, B.S.2    Wood, M.A.3
  • 37
    • 0028116076 scopus 로고
    • Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium- blocking agent
    • Bargheer K., Bode F., Klein H.U., Trappe H.J., Franz M.R., Lichtlen P.R. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium- blocking agent. Eur Heart J. 15:1994;1409-1414.
    • (1994) Eur Heart J , vol.15 , pp. 1409-1414
    • Bargheer, K.1    Bode, F.2    Klein, H.U.3    Trappe, H.J.4    Franz, M.R.5    Lichtlen, P.R.6
  • 38
    • 0028106374 scopus 로고
    • Risks and benefits of antiarrhythmic therapy
    • Roden D.M. Risks and benefits of antiarrhythmic therapy. N Engl J Med. 331:1994;785-791.
    • (1994) N Engl J Med , vol.331 , pp. 785-791
    • Roden, D.M.1
  • 40
    • 24544448349 scopus 로고
    • Modulation of the electrophysiologic effects af ambasilide induced by β-adrenergic stimulation in isolated ventricular myocytes
    • Napolitano C., Diehl L., Schwartz P.L., Priori S.G. Modulation of the electrophysiologic effects af ambasilide induced by β-adrenergic stimulation in isolated ventricular myocytes. J Am Coll Cardiol. 23:1994;444A.
    • (1994) J Am Coll Cardiol , vol.23
    • Napolitano, C.1    Diehl, L.2    Schwartz, P.L.3    Priori, S.G.4
  • 41
    • 0027178409 scopus 로고
    • Electrophysiologic effects of E-4031, a new class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias
    • Isomoto S., Shimizu A., Konoe A.et al. Electrophysiologic effects of E-4031, a new class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias. Am J Cardiol. 71:1993;1464-1467.
    • (1993) Am J Cardiol , vol.71 , pp. 1464-1467
    • Isomoto, S.1    Shimizu, A.2    Konoe, A.3
  • 42
    • 4243493847 scopus 로고
    • Electrocardiographic effects of oral MK-499, a new class III antiarrhythmic agent in patients with coronary disease
    • Singh B.N., Ellenbogen K.A., Zoble R.G.et al. Electrocardiographic effects of oral MK-499, a new class III antiarrhythmic agent in patients with coronary disease. J Am Coll Cardiol. 23:1994;92A.
    • (1994) J Am Coll Cardiol , vol.23
    • Singh, B.N.1    Ellenbogen, K.A.2    Zoble, R.G.3
  • 43
    • 0028558526 scopus 로고
    • Amiodarone - Associated proarrhytmic effect - A review with special reference to torsade de pointes tachycardia
    • Hohnloser S.H., Klingenheben T., Singh B.N. Amiodarone - associated proarrhytmic effect - A review with special reference to torsade de pointes tachycardia. Ann Intern Med. 121:1994;529-535.
    • (1994) Ann Intern Med , vol.121 , pp. 529-535
    • Hohnloser, S.H.1    Klingenheben, T.2    Singh, B.N.3
  • 44
    • 0028927451 scopus 로고
    • Regulation of potassium channels by non-sedating antihistamines
    • Berul C.I., Morad M. Regulation of potassium channels by non-sedating antihistamines. Circulation. 91:1995;2220-2225.
    • (1995) Circulation , vol.91 , pp. 2220-2225
    • Berul, C.I.1    Morad, M.2
  • 45
    • 0028082351 scopus 로고
    • Clinical relevance in the generation of U waves, triggered activity and torsades de pointes
    • Antzelevitch C., Sicouri S. Clinical relevance in the generation of U waves, triggered activity and torsades de pointes. J Am Coll Cardiol. 23:1994;259-277.
    • (1994) J Am Coll Cardiol , vol.23 , pp. 259-277
    • Antzelevitch, C.1    Sicouri, S.2
  • 46
    • 0025164907 scopus 로고
    • Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse-use dependence
    • Hondeghem L.M., Snyders D.J. Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse-use dependence. Circulation. 81:1990;686-690.
    • (1990) Circulation , vol.81 , pp. 686-690
    • Hondeghem, L.M.1    Snyders, D.J.2
  • 47
    • 0000955543 scopus 로고
    • Frequency-dependent electrophysiologic effects of dofetilide in humans
    • Sager P.T. Frequency-dependent electrophysiologic effects of dofetilide in humans. Circulation. 92(Suppl I):1995;I-774.
    • (1995) Circulation , vol.92 , Issue.SUPPL. I , pp. 774
    • Sager, P.T.1
  • 48
    • 0030025856 scopus 로고    scopus 로고
    • Assessment of reserve-use dependent blocking actions of class III antiarrhythmic drugs by 24-hour holter electrocardiography
    • Okada Y., Ogawa S., Sadanaga T., Mitamura H. Assessment of reserve-use dependent blocking actions of class III antiarrhythmic drugs by 24-hour holter electrocardiography. J Am Coll Cardiol. 27:1996;84-89.
    • (1996) J Am Coll Cardiol , vol.27 , pp. 84-89
    • Okada, Y.1    Ogawa, S.2    Sadanaga, T.3    Mitamura, H.4
  • 53
    • 0029079155 scopus 로고
    • Comparison of hemodynamic effects and plasma cyclic guanosin monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure
    • Tsutamoto T., Kinoshita M., Hisanaga T., Maeda Y., Maeda K., Wada A., Fukai D., Yoshida S. Comparison of hemodynamic effects and plasma cyclic guanosin monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure. Am J Cardiol. 75:1995;1162-1165.
    • (1995) Am J Cardiol , vol.75 , pp. 1162-1165
    • Tsutamoto, T.1    Kinoshita, M.2    Hisanaga, T.3    Maeda, Y.4    Maeda, K.5    Wada, A.6    Fukai, D.7    Yoshida, S.8
  • 55
    • 0024395336 scopus 로고
    • A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris
    • Camm J.A., Maltz M.B. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris. Am J Cardiol. 63:1989;61J-65J.
    • (1989) Am J Cardiol , vol.63
    • Camm, J.A.1    Maltz, M.B.2
  • 56
    • 0024995674 scopus 로고
    • Comparison of nicorandil and atenolol in stable angina pectoris
    • Hugues L.O., Rose E.L., Lahiri A., Raftery E.B. Comparison of nicorandil and atenolol in stable angina pectoris. Am J Cardiol. 66:1990;679-682.
    • (1990) Am J Cardiol , vol.66 , pp. 679-682
    • Hugues, L.O.1    Rose, E.L.2    Lahiri, A.3    Raftery, E.B.4
  • 57
    • 0026748339 scopus 로고
    • Pharmacological evidence for a role of ATP dependent potassium channels in myocardial stunning
    • Auchampach J.A., Maruyana M., Cavero I., Gross G.J. Pharmacological evidence for a role of ATP dependent potassium channels in myocardial stunning. Circulation. 86:1992;311-319.
    • (1992) Circulation , vol.86 , pp. 311-319
    • Auchampach, J.A.1    Maruyana, M.2    Cavero, I.3    Gross, G.J.4
  • 58
    • 0027548579 scopus 로고
    • ATP channels: An endogenous protective mechanism during repetitive ischemia
    • ATP channels: an endogenous protective mechanism during repetitive ischemia. Am J Physiol. 264:1993;H495-H504.
    • (1993) Am J Physiol , vol.264
    • Yao, Z.1    Cavero, I.2    Gross, G.J.3
  • 59
    • 0029073627 scopus 로고
    • Ischaemic preconditioning: Is it clinically relevant?
    • Verdouw P.D., Gho B.C.G., Dunker D.J. Ischaemic preconditioning: is it clinically relevant? Eur Heart J. 16:1995;1169-1176.
    • (1995) Eur Heart J , vol.16 , pp. 1169-1176
    • Verdouw, P.D.1    Gho, B.C.G.2    Dunker, D.J.3
  • 61
    • 0029081730 scopus 로고
    • Activation of ATP-sensitive potassium channels: A novel pharmacological approach to myocardial protection?
    • Hearse D.J. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection? Cardiovasc Res. 30:1995;1-17.
    • (1995) Cardiovasc Res , vol.30 , pp. 1-17
    • Hearse, D.J.1
  • 62
    • 0028182423 scopus 로고
    • ATP channel opener Bimakalim on coronary blood low, monophasic action potential duration and infarct size in dogs
    • ATP channel opener Bimakalim on coronary blood low, monophasic action potential duration and infarct size in dogs. Circulation. 89:1994;1769-1775.
    • (1994) Circulation , vol.89 , pp. 1769-1775
    • Yao, Z.1    Garrett, J.2    Gross, G.J.3
  • 66
    • 85047680900 scopus 로고
    • Electrophysiological effects of ATP sensitive potassium channel modulation: Implications for arrhythmogenesis
    • Wilde A.M., Janse M.J. Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis. Cardiovasc Res. 28:1994;16-24.
    • (1994) Cardiovasc Res , vol.28 , pp. 16-24
    • Wilde, A.M.1    Janse, M.J.2
  • 67
    • 85047675589 scopus 로고
    • Blockers of ATP sensitive potassium current are of potential benefit in ischaemic heart disease
    • Siegel P. Blockers of ATP sensitive potassium current are of potential benefit in ischaemic heart disease. Cardiovasc Res. 28:1994;31-32.
    • (1994) Cardiovasc Res , vol.28 , pp. 31-32
    • Siegel, P.1
  • 68
    • 85023412322 scopus 로고
    • ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease
    • Cavero I., Premmereur J. ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease. Cardiovasc Res. 28:1994;32-33.
    • (1994) Cardiovasc Res , vol.28 , pp. 32-33
    • Cavero, I.1    Premmereur, J.2
  • 69
    • 0028126596 scopus 로고
    • + channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts
    • + channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts. Circulation. 90:1994;2213-2224.
    • (1994) Circulation , vol.90 , pp. 2213-2224
    • Koumi, S.I.1    Arentzen, C.E.2    Backer, C.L.3    Wasserstrom, A.4
  • 70
    • 0031041032 scopus 로고    scopus 로고
    • f, in ventricular myocytes from human failing hearts
    • f, in ventricular myocytes from human failing hearts. Circulation. 95:1997;568-571.
    • (1997) Circulation , vol.95 , pp. 568-571
    • Cerbai, E.1    Pino, R.2    Porciatti, F.3
  • 72
    • 0030012835 scopus 로고    scopus 로고
    • Missense mutation in the pore region of HERG causes familial long QT syndrome
    • Benson D.W., MacRae C.A., Vesely M.R.et al. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation. 93:1996;1791-1795.
    • (1996) Circulation , vol.93 , pp. 1791-1795
    • Benson, D.W.1    MacRae, C.A.2    Vesely, M.R.3
  • 74
    • 0029825403 scopus 로고    scopus 로고
    • Molecular physiology and pharmacology of HERG
    • Kiehn J., Lacerda A.E., Wible B., Brown A.M. Molecular physiology and pharmacology of HERG. Circulation. 94:1996;2572-2579.
    • (1996) Circulation , vol.94 , pp. 2572-2579
    • Kiehn, J.1    Lacerda, A.E.2    Wible, B.3    Brown, A.M.4
  • 76
    • 0029761822 scopus 로고    scopus 로고
    • HERG, a primary human ventricular target of the non-sedating antihistamine terfenadine
    • Roy M.L., Dumaine R., Brown A.M. HERG, a primary human ventricular target of the non-sedating antihistamine terfenadine. Circulation. 94:1996;817-823.
    • (1996) Circulation , vol.94 , pp. 817-823
    • Roy, M.L.1    Dumaine, R.2    Brown, A.M.3
  • 77
    • 0000035081 scopus 로고
    • Cisapride and torsades de pointes
    • Wolfe S.M., Ahmad S.R. Cisapride and torsades de pointes. Lancet. 345:1995;508.
    • (1995) Lancet , vol.345 , pp. 508
    • Wolfe, S.M.1    Ahmad, S.R.2
  • 78
    • 0342304497 scopus 로고
    • Prolongation of QT interval induced by erythromycin may be explained by an inhibition of the rapid component of the delayed rectifier potassium IKr
    • Daleau P., Turgeon J. Prolongation of QT interval induced by erythromycin may be explained by an inhibition of the rapid component of the delayed rectifier potassium IKr. Circulation. 90:1994;1-248.
    • (1994) Circulation , vol.90 , pp. 1-248
    • Daleau, P.1    Turgeon, J.2
  • 79
    • 0030468097 scopus 로고    scopus 로고
    • Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes
    • Antzelevitch C., Sun Z.Q., Zhang Z.Q., Yan G.X. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J Am Coll Cardiol. 28:1996;1836-1848.
    • (1996) J Am Coll Cardiol , vol.28 , pp. 1836-1848
    • Antzelevitch, C.1    Sun, Z.Q.2    Zhang, Z.Q.3    Yan, G.X.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.